ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE (CPDA-1) (TERUFLEX Blood Bag System Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1)) Nursing Considerations

Join NURSING.com to watch the full lesson now.

Included In This Lesson

Outline

What is the Generic Name

ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE (CPDA-1)

What is the Trade Name for ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE (CPDA-1)

TERUFLEX Blood Bag System Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1)

What is the Indication for ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE (CPDA-1)

  • For the collection of 250 mL of Whole Blood Revised 2015-12 N-BB-A 3 FULL PRESCRIBING INFORMATION * Sections or subsections omitted from the Full Prescribing Information are not listed [includes sections 4, 6, 7, 8, 9, 10, 12, 13, 14, 15 and 17]. 1. INDICATIONS AND USAGE 1.1. Read these instructions carefully before use. 1.2. Rx ONLY. 1.3. Intended for the collection, processing and preservation of Whole Blood and blood components. Not intended for direct intravenous infusion. 1.4. For the collection of 250 mL ¬±10% Whole Blood: 1.4.1. From elderly, pediatric, or smaller autologous donors who may not tolerate larger blood collections. 1.4.2. For blood collections as directed by a patient’s physician. 1.5. NOTE : Production of Platelets and Plasma is not intended with this product. Image of Fig. 1 Sealing with tape

 

 

View Our Nursing Pharmacology Course

 

References: https://open.fda.gov/

 

Other Pharm Resources
Join NURSING.com to watch the full lesson now.
[NextGen]
[NextGen]